Solvonis Therapeutics plc
Status: Publicly traded
Direct answer
Solvonis Therapeutics plc is publicly traded on LSE under the ticker SVNS.L.
Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across Europe. The company offers a diverse portfolio of specialized products: GRAFTABOND: A line of graft/block copolymers designed to robustly combine various polymers with...
Can you invest in Solvonis Therapeutics plc?
Yes. Solvonis Therapeutics plc trades publicly on LSE as SVNS.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Solvonis Therapeutics plc
Detailed equity research is provided by MarketSnap.